Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1997]

SABCS congress news: Trastuzumab plus chemotherapy for maximum benefit

SABCS congress news: Trastuzumab plus chemotherapy for maximum benefit

Physical activity associated with lower risk of mortality in men with history of colon cancer

Physical activity associated with lower risk of mortality in men with history of colon cancer

SABCS congress news: Bevacizumab plus chemotherapy 'improves' progression-free survival

SABCS congress news: Bevacizumab plus chemotherapy 'improves' progression-free survival

SABCS congress news: CTCs that undergo EMT may escape conventional detection

SABCS congress news: CTCs that undergo EMT may escape conventional detection

SABCS congress news: Chemotherapy plus sorafenib 'offers breast cancer patients improvement in response rate'

SABCS congress news: Chemotherapy plus sorafenib 'offers breast cancer patients improvement in respo...

SABCS congress news: Promising results from 'Notch' pathway inhibitor tests

SABCS congress news: Promising results from 'Notch' pathway inhibitor tests

SABCS congress news: Exemestane taken as initial endocrine therapy 'will improve relapse-free survival'

SABCS congress news: Exemestane taken as initial endocrine therapy 'will improve relapse-free surviv...

SABCS congress news: 'Use of bisphosphonates' reduces risk of postmenopausal breast cancer

SABCS congress news: 'Use of bisphosphonates' reduces risk of postmenopausal breast cancer

SABCS congress news: Fewer invasive breast cancers for bisphosphonate users

SABCS congress news: Fewer invasive breast cancers for bisphosphonate users

SABCS congress news: Zoledronic acid 'safe and effective' in preventing bone loss

SABCS congress news: Zoledronic acid 'safe and effective' in preventing bone loss

More from ecancer